Kat5 deficiency in alveolar type II cells licenses STAT6-driven glycolytic reprogramming and pulmonary fibrosis.
Authors: Yang Y, Ling Y, Li J, Li Q, Feng Y, Xiao J, Ma Y, Tao S
Journal: Nature communications
group therapy
mental health
open access